Literature DB >> 12589169

Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28.

Marlies K A Dankers1, Dave L Roelen, Ellen M W Van Der Meer-Prins, Peter De Lange, Nelleke Korfage, Jacqueline M A Smits, Guido G Persijn, Ken I Welsh, Ilias I N Doxiadis, Frans H J Claas.   

Abstract

The immunogenicity of human leukocyte antigen (HLA)-A2 versus HLA-A28 was analyzed by antibody production, cytotoxic T-lymphocyte (CTL) induction, and graft survival. We observed that an HLA-A2 mismatched child in HLA-A28 women leads to HLA-A2 specific antibodies in 32% of the women (n=31), whereas in the case of an HLA-A28 child and HLA-A2 women (n=30), no HLA-A28 specific antibodies were found ( P<0.002). Also, the CTL precursor frequencies were significantly lower against HLA-A28 compared with CTLp frequencies against HLA-A2 ( P=0.012). Finally, the kidney graft survival was slightly better in HLA-A2 positive recipients transplanted with HLA-A28 mismatches. We can conclude that single HLA-A28 mismatches are less immunogenic in HLA-A2 individuals compared with single HLA-A2 mismatches in HLA-A28 individuals, which is probably because the mismatched epitopes on the HLA-A2 molecule are unique epitopes, whereas the mismatched epitopes on HLA-A28 are shared by other HLA-A and HLA-B molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589169     DOI: 10.1097/01.TP.0000044456.51462.E2

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

Review 1.  The generation and maintenance of serum alloantibody.

Authors:  M R Clatworthy; M Espeli; N Torpey; K G C Smith
Journal:  Curr Opin Immunol       Date:  2010-10       Impact factor: 7.486

2.  Differences in immunogenicity of HLA antigens and the impact of cross-reactivity on the humoral response.

Authors:  Donna P Lucas; Mary S Leffell; Andrea A Zachary
Journal:  Transplantation       Date:  2015-01       Impact factor: 4.939

3.  Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.

Authors:  Lara Schawalder; Gideon Hönger; Marc Kleiser; Michelle R van Heck; Loes A L van de Pasch; Sanne Vendelbosch; Erik H Rozemuller; Stefan Schaub
Journal:  HLA       Date:  2020-10-28       Impact factor: 4.513

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.